Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Whitehouse

Showing results (161-170 of 341) with videos related to

Pageof 35
Sort By:
Annals of Neurology|September 1, 1988
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsyM Tabaton, P J Whitehouse, G Perry, et al.
Scientific Reports|August 5, 2016
Boron isotope fractionation in magma via crustal carbonate dissolutionFrances M Deegan, Valentin R Troll, Martin J Whitehouse, et al.
Neurology|March 1, 1990
Complex visual disturbances in Alzheimer's diseaseM F Mendez, M A Mendez, R Martin, et al.
Scientific Reports|November 21, 2020
Exceptional sulfur and iron isotope enrichment in millimetre-sized, early Palaeozoic animal burrowsDario Harazim, Joonas J Virtasalo, Kathryn C Denommee, et al.
The Journal of Endocrinology|May 1, 1992
Effects of dopamine, high potassium concentration and field stimulation on the secretion of aldosterone by the perfused rat adrenal glandI D Porter, B J Whitehouse, G M Price, et al.
Endocrine Research|February 24, 2001
Inhibition of protein tyrosine phosphatase activity blocks shape change & steroidogenesis in Y1 cellsB J Whitehouse, S L Gyles, C J Burns, et al.
Alzheimer Disease and Associated Disorders|June 18, 1999
Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task forceC A Cohen, P J Whitehouse, S G Post, et al.
The Gerontologist|June 16, 2004
Anti-aging medicine: can consumers be better protected?Maxwell J Mehlman, Robert H Binstock, Eric T Juengst, et al.
Brain Research|November 13, 1995
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's diseaseS Shimohama, S Fujimoto, M Chachin, et al.
Alzheimer Disease and Associated Disorders|January 7, 1999
Clinical trial designs for demonstrating disease-course-altering effects in dementiaP J Whitehouse, B Kittner, M Roessner, et al.
Pageof 35

Showing results (161-170 of 341) with videos related to

Sort By:
Pageof 35
Annals of Neurology|September 1, 1988
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsyM Tabaton, P J Whitehouse, G Perry, et al.
Scientific Reports|August 5, 2016
Boron isotope fractionation in magma via crustal carbonate dissolutionFrances M Deegan, Valentin R Troll, Martin J Whitehouse, et al.
Neurology|March 1, 1990
Complex visual disturbances in Alzheimer's diseaseM F Mendez, M A Mendez, R Martin, et al.
Scientific Reports|November 21, 2020
Exceptional sulfur and iron isotope enrichment in millimetre-sized, early Palaeozoic animal burrowsDario Harazim, Joonas J Virtasalo, Kathryn C Denommee, et al.
The Journal of Endocrinology|May 1, 1992
Effects of dopamine, high potassium concentration and field stimulation on the secretion of aldosterone by the perfused rat adrenal glandI D Porter, B J Whitehouse, G M Price, et al.
Endocrine Research|February 24, 2001
Inhibition of protein tyrosine phosphatase activity blocks shape change & steroidogenesis in Y1 cellsB J Whitehouse, S L Gyles, C J Burns, et al.
Alzheimer Disease and Associated Disorders|June 18, 1999
Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task forceC A Cohen, P J Whitehouse, S G Post, et al.
The Gerontologist|June 16, 2004
Anti-aging medicine: can consumers be better protected?Maxwell J Mehlman, Robert H Binstock, Eric T Juengst, et al.
Brain Research|November 13, 1995
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's diseaseS Shimohama, S Fujimoto, M Chachin, et al.
Alzheimer Disease and Associated Disorders|January 7, 1999
Clinical trial designs for demonstrating disease-course-altering effects in dementiaP J Whitehouse, B Kittner, M Roessner, et al.
Pageof 35